Why U.S. Hospitals Must Evolve Beyond the Old International Patient Model
For decades, U.S. hospitals viewed international patient programs as a threefold opportunity—boosting revenue, reputation, and research. By attracting patients from around the world for high-end specialty care, they not only generated income but also reinforced their global prestige and advanced clinical experience.
However, recent years have revealed how vulnerable that model truly is. The global market for Mode 2 medical services—where patients travel abroad for care—was valued between $20–30 billion in 2023, with U.S. hospitals once capturing roughly 20% of that share. Yet despite the reopening of borders post-pandemic, the flow of medical travelers has not rebounded.
Why the Market Has Changed
Several forces are reshaping global patient mobility and eroding the United States’ historical dominance in this sector:
- Source markets are evolving. Once key referral regions in the Middle East, Latin America, and Asia are now retaining more patients locally.
- Investment in domestic excellence. Countries such as China, Saudi Arabia, and Mexico are pouring billions into modern hospital infrastructure, physician training, and medical technology—creating centers of excellence that compete directly with U.S. facilities.
- Aggressive destination marketing. Former source countries are now marketing themselves as destinations, not dependents. Medical tourism councils, accreditation programs, and government-backed initiatives have helped rebrand nations like the UAE and Thailand as providers of world-class care.
- Cost and access pressures. The U.S. healthcare system remains among the most expensive globally, and even affluent international patients are increasingly looking for alternatives that combine quality, affordability, and convenience.
The result: international patient volumes to U.S. hospitals have plateaued—or, in many cases, declined—while global competition has intensified.
From Patients to Partnerships: A New Global Health Playbook
To stay competitive, U.S. hospitals must shift from a patient-acquisition mindset to a partnership-building strategy. This means expanding global engagement through education, technology, and collaboration—leveraging all four modes of cross-border healthcare trade under the GATS framework.
Emerging opportunities include:
- Digital Health (Mode 1): Expanding U.S. expertise through telemedicine, remote training, and digital diagnostics.
- Selective Medical Travel (Mode 2): Maintaining specialized international services for complex cases where U.S. leadership remains strong.
- Overseas Partnerships (Mode 3): Establishing regional affiliates, research collaborations, or branded care centers abroad.
- Talent and Knowledge Exchange (Mode 4): Fostering global mobility of clinicians and shared professional development.
By embracing these multi-modal approaches, U.S. institutions can sustain influence in a rapidly transforming global market—one that values accessibility, collaboration, and innovation over geography alone.
The Road Ahead
The next phase of global healthcare trade won’t be defined by how many patients travel, but by how far knowledge, technology, and collaboration can reach. Success will depend on strategic alignment between hospitals, educators, and health entrepreneurs who recognize that global care is no longer about place—it’s about presence.
💡 Be sure to join moderator, Irving Stackpole, for “Reframing the Global HealthScape for US Hospitals: Next-Gen Competitive Models” at the 2025 USCIPP Annual Meeting, December 5, 2025 | 10:45–11:30 AM ET, with Elizabeth Ziemba, Founder and President, Medical Tourism Training, Inc., and Deepak Asudani, MD, International Medical Director, UC San Diego Health.
👉 Learn more: https://stackpoleassociates.com/2025-uscipp/